Drugs / HydroVax-005 CHIKV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06669208 | Nov 2024 → Feb 2026 | chikungunya | Najit Technologies, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HydroVax-005 CHIKV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06669208 ↗ |
| Modality | Vaccine | “Inactivated Chikungunya Virus Vaccine” NCT06669208 ↗ |
| Route | Intramuscular | “given intramuscularly” NCT06669208 ↗ |